Boundless Bio, Inc.
Calidad de datos: 83%
BOLD
Nasdaq
Manufacturing
Chemicals
$1.15
▼
$0.01
(-0.43%)
Cap. Mercado: 25.66 M
Precio
$1.15
Cap. Mercado
25.66 M
Rango del Día
$1.14 — $1.19
Rango de 52 Semanas
$0.96 — $1.78
Volumen
94,040
Apertura $1.14
Promedio 50D / 200D
$1.14
0.05% above
Promedio 50D / 200D
$1.18
3.24% below
Quick Summary
Puntos Clave
Negative free cash flow of -47.21 M
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-49.98%
Above sector avg (-51.02%)
ROIC-30.70%
Net MarginN/A
Op. MarginN/A
Seguridad
Debt / Equity
N/A
Current Ratio10.14
Interest CoverageN/A
Valoración
PE (TTM)
-0.44
Above sector avg (-1.98)
P/B Ratio0.23
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)
Comparación con Pares
vs mediana del sector Manufacturing (44 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -0.4 | -2.0 |
| P/B | 0.2 | 5.1 |
| ROE % | -50.0 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -58.20 M |
| ROE | -49.98% | ROA | -33.43% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -47.21 M |
| ROIC | -30.70% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 10.14 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 108.31 M | Tangible Book Value | 110.17 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.44 | Forward P/E | N/A |
| P/B Ratio | 0.23 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -184.00% | ||
| Market Cap | 25.66 M | Enterprise Value | 10.68 M |
| Per Share | |||
| EPS (Diluted TTM) | -2.60 | Revenue / Share | N/A |
| FCF / Share | -2.11 | OCF / Share | -2.08 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 81.12% |
| SBC-Adj. FCF | -53.33 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Revenue | — | — |
| Net Income | -58.20 M | -65.36 M |
| EPS (Diluted) | -2.60 | -3.85 |
| Gross Profit | — | — |
| Operating Income | -63.55 M | -73.27 M |
| EBITDA | — | — |
| R&D Expenses | 44.85 M | 55.27 M |
| SG&A Expenses | — | — |
| D&A | 1.25 M | 1.09 M |
| Interest Expense | — | — |
| Income Tax | 0.0 | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 |
|---|---|---|
| Total Assets | 157.06 M | 206.41 M |
| Total Liabilities | 58.41 M | 55.77 M |
| Shareholders' Equity | 98.65 M | 150.64 M |
| Total Debt | — | — |
| Cash & Equivalents | 17.87 M | 26.59 M |
| Current Assets | 109.61 M | 154.39 M |
| Current Liabilities | 12.54 M | 8.14 M |
{"event":"ticker_viewed","properties":{"ticker":"BOLD","listing_kind":"stock","pathname":"/stocks/bold","exchange":"Nasdaq","country":"US"}}